during the swiftly evolving discipline of cancer therapeutics, knowledge the intricate mechanisms of Antibody-Drug Conjugates (ADCs) is crucial for building efficient therapies. One of the more promising methods is the use of in vitro bystander influence assays, which Participate in a pivotal position in improving therapeutic efficacy. These assays